These risks include persons with personal or family history with cardiovascular diseases, thyroid tumors, chronic kidney, renal function, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome and hepatic failure, as well as those patients already receiving insulin therapy and certain diabetes medications
What's New with GLP-1 Coverage in 2026 While GLP-1 agonists have been around for over a decade now, they've seen a big jump in popularity in the last couple of years
Discover ingredient solutions for sugar reduction, fibre enrichment and plant-based proteins to meet GLP-1-driven consumer demands
Studies indicate that BCAAs, particularly leucine and valine, can significantly attenuate body weight loss and increase skeletal muscle wet weight in tumor-bearing mice through mechanisms involving enhanced protein synthesis and reduced protein degradation (55, 56)
Now, you can get one bottle of 30 servings in every formula for the same flat price, which varies depending on how youre ordering it
In the same press release, Prime Therapeutics vice president and medical director Marci Chodroff, MD, said, Care management is essential for those taking GLP-1 drugs, and when providers and prescribers have access to real-world data, they're better informed to manage drug dosages, monitor for potential adverse effects and help with other areas, such as diet and exercise coaching